US Stock MarketDetailed Quotes

LSTA Lisata Therapeutics

Watchlist

2.840
-0.040-1.39%

Close Nov 26 16:00 ET

23.84MMarket Cap-1131P/E (TTM)

Lisata Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

Operating revenue

--0

Cost of revenue

Gross profit

Operating expense

-10.53%5.34M

-19.67%5.52M

-3.55%6.6M

-55.37%25.71M

-7.87%6.03M

-84.19%5.96M

2.31%6.88M

3.38%6.84M

98.28%57.6M

-4.51%6.54M

Selling and administrative expenses

8.13%2.79M

-21.30%2.92M

-8.32%3.36M

-8.25%12.97M

-9.44%3.01M

-35.27%2.58M

6.51%3.71M

9.83%3.67M

23.24%14.14M

18.66%3.33M

-General and administrative expense

8.13%2.79M

-21.30%2.92M

-8.32%3.36M

-8.25%12.97M

-9.44%3.01M

-35.27%2.58M

6.51%3.71M

--3.67M

23.24%14.14M

18.66%3.33M

Research and development costs

-24.79%2.54M

-17.74%2.6M

1.95%3.24M

-70.70%12.73M

-6.25%3.01M

-89.98%3.38M

-2.23%3.16M

-3.17%3.18M

147.27%43.46M

-20.56%3.21M

Operating profit

10.53%-5.34M

19.67%-5.52M

3.55%-6.6M

55.37%-25.71M

7.87%-6.03M

84.19%-5.96M

-2.31%-6.88M

-3.38%-6.84M

-98.28%-57.6M

4.51%-6.54M

Net non-operating interest income expense

Other net income (expense)

-42.25%406K

-7.53%479K

-38.81%402K

182.94%2.54M

20.00%660K

108.61%703K

451.06%518K

872.94%657K

1,080.26%897K

900.00%550K

Gain on sale of security

-36.83%451K

-26.20%493K

-12.09%589K

158.94%2.72M

20.68%671K

111.87%714K

610.64%668K

963.49%670K

596.69%1.05M

1,290.00%556K

Other non- operating income (expenses)

-309.09%-45K

90.67%-14K

-1,338.46%-187K

-20.00%-186K

-83.33%-11K

---11K

---150K

91.22%-13K

-106.67%-155K

-140.00%-6K

Income before tax

6.29%-4.93M

20.65%-5.04M

-0.19%-6.2M

59.14%-23.17M

10.43%-5.37M

85.93%-5.26M

4.06%-6.36M

7.73%-6.19M

-95.71%-56.7M

11.83%-5.99M

Income tax

-798K

6.01%-2.33M

-2.33M

-64.39%-2.48M

Net income

6.29%-4.93M

-25.25%-5.04M

12.70%-5.4M

61.57%-20.84M

10.43%-5.37M

85.93%-5.26M

39.22%-4.03M

-46.40%-6.19M

-97.43%-54.23M

11.83%-5.99M

Net income continuous Operations

6.29%-4.93M

-25.25%-5.04M

12.70%-5.4M

61.57%-20.84M

10.43%-5.37M

85.93%-5.26M

39.22%-4.03M

-46.40%-6.19M

-97.43%-54.23M

11.83%-5.99M

Minority interest income

Net income attributable to the parent company

6.29%-4.93M

-25.25%-5.04M

12.70%-5.4M

61.57%-20.84M

10.43%-5.37M

85.93%-5.26M

39.22%-4.03M

-46.40%-6.19M

-97.43%-54.23M

11.83%-5.99M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

6.29%-4.93M

-25.25%-5.04M

12.70%-5.4M

61.57%-20.84M

10.43%-5.37M

85.93%-5.26M

39.22%-4.03M

-46.40%-6.19M

-97.43%-54.23M

11.83%-5.99M

Basic earnings per share

9.23%-0.59

-22.00%-0.61

15.58%-0.65

75.36%-2.58

12.95%-0.66

91.75%-0.65

69.51%-0.5

26.67%-0.77

-40.54%-10.47

55.13%-0.7582

Diluted earnings per share

9.23%-0.59

-22.00%-0.61

15.58%-0.65

75.36%-2.58

12.95%-0.66

91.75%-0.65

69.51%-0.5

26.67%-0.77

-40.54%-10.47

55.13%-0.7582

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	0	0	0	0	0	0	0	0	0
Operating revenue	--0	--0	--0	--0	--0	--0	--0	--0	--0	--0
Cost of revenue
Gross profit
Operating expense	-10.53%5.34M	-19.67%5.52M	-3.55%6.6M	-55.37%25.71M	-7.87%6.03M	-84.19%5.96M	2.31%6.88M	3.38%6.84M	98.28%57.6M	-4.51%6.54M
Selling and administrative expenses	8.13%2.79M	-21.30%2.92M	-8.32%3.36M	-8.25%12.97M	-9.44%3.01M	-35.27%2.58M	6.51%3.71M	9.83%3.67M	23.24%14.14M	18.66%3.33M
-General and administrative expense	8.13%2.79M	-21.30%2.92M	-8.32%3.36M	-8.25%12.97M	-9.44%3.01M	-35.27%2.58M	6.51%3.71M	--3.67M	23.24%14.14M	18.66%3.33M
Research and development costs	-24.79%2.54M	-17.74%2.6M	1.95%3.24M	-70.70%12.73M	-6.25%3.01M	-89.98%3.38M	-2.23%3.16M	-3.17%3.18M	147.27%43.46M	-20.56%3.21M
Operating profit	10.53%-5.34M	19.67%-5.52M	3.55%-6.6M	55.37%-25.71M	7.87%-6.03M	84.19%-5.96M	-2.31%-6.88M	-3.38%-6.84M	-98.28%-57.6M	4.51%-6.54M
Net non-operating interest income expense
Other net income (expense)	-42.25%406K	-7.53%479K	-38.81%402K	182.94%2.54M	20.00%660K	108.61%703K	451.06%518K	872.94%657K	1,080.26%897K	900.00%550K
Gain on sale of security	-36.83%451K	-26.20%493K	-12.09%589K	158.94%2.72M	20.68%671K	111.87%714K	610.64%668K	963.49%670K	596.69%1.05M	1,290.00%556K
Other non- operating income (expenses)	-309.09%-45K	90.67%-14K	-1,338.46%-187K	-20.00%-186K	-83.33%-11K	---11K	---150K	91.22%-13K	-106.67%-155K	-140.00%-6K
Income before tax	6.29%-4.93M	20.65%-5.04M	-0.19%-6.2M	59.14%-23.17M	10.43%-5.37M	85.93%-5.26M	4.06%-6.36M	7.73%-6.19M	-95.71%-56.7M	11.83%-5.99M
Income tax	0	0	-798K	6.01%-2.33M	0	0	-2.33M	0	-64.39%-2.48M	0
Net income	6.29%-4.93M	-25.25%-5.04M	12.70%-5.4M	61.57%-20.84M	10.43%-5.37M	85.93%-5.26M	39.22%-4.03M	-46.40%-6.19M	-97.43%-54.23M	11.83%-5.99M
Net income continuous Operations	6.29%-4.93M	-25.25%-5.04M	12.70%-5.4M	61.57%-20.84M	10.43%-5.37M	85.93%-5.26M	39.22%-4.03M	-46.40%-6.19M	-97.43%-54.23M	11.83%-5.99M
Minority interest income	0	0	0	0	0	0	0	0	0	0
Net income attributable to the parent company	6.29%-4.93M	-25.25%-5.04M	12.70%-5.4M	61.57%-20.84M	10.43%-5.37M	85.93%-5.26M	39.22%-4.03M	-46.40%-6.19M	-97.43%-54.23M	11.83%-5.99M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	6.29%-4.93M	-25.25%-5.04M	12.70%-5.4M	61.57%-20.84M	10.43%-5.37M	85.93%-5.26M	39.22%-4.03M	-46.40%-6.19M	-97.43%-54.23M	11.83%-5.99M
Basic earnings per share	9.23%-0.59	-22.00%-0.61	15.58%-0.65	75.36%-2.58	12.95%-0.66	91.75%-0.65	69.51%-0.5	26.67%-0.77	-40.54%-10.47	55.13%-0.7582
Diluted earnings per share	9.23%-0.59	-22.00%-0.61	15.58%-0.65	75.36%-2.58	12.95%-0.66	91.75%-0.65	69.51%-0.5	26.67%-0.77	-40.54%-10.47	55.13%-0.7582
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data